Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type

Biopsies and cell lines of natural killer/T-cell lymphoma, nasal type (NKTCL) were subject to combined gene expression profiling and array-based comparative genomic hybridization analyses. Compared with peripheral T-cell lymphoma, not otherwise specified, NKTCL had greater transcript levels for NK-c...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 115; no. 6; pp. 1226 - 1237
Main Authors Huang, Yenlin, de Reyniès, Aurélien, de Leval, Laurence, Ghazi, Bouchra, Martin-Garcia, Nadine, Travert, Marion, Bosq, Jacques, Brière, Josette, Petit, Barbara, Thomas, Emilie, Coppo, Paul, Marafioti, Teresa, Emile, Jean-François, Delfau-Larue, Marie-Hélène, Schmitt, Christian, Gaulard, Philippe
Format Journal Article
LanguageEnglish
Published Washington, DC Elsevier Inc 11.02.2010
Americain Society of Hematology
American Society of Hematology
SeriesLymphoid Neoplasia
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Biopsies and cell lines of natural killer/T-cell lymphoma, nasal type (NKTCL) were subject to combined gene expression profiling and array-based comparative genomic hybridization analyses. Compared with peripheral T-cell lymphoma, not otherwise specified, NKTCL had greater transcript levels for NK-cell and cytotoxic molecules, especially granzyme H. Compared with normal NKcells, tumors were closer to activated than resting cells and overexpressed several genes related to vascular biology, Epstein-Barr Virus–induced genes, and PDGFRA. Notably, platelet-derived growth factor receptor α and its phosphorylated form were confirmed at the protein level, and in vitro the MEC04 NKTCL cell line was sensitive to imatinib. Deregulation of the AKT, Janus kinase–signal transducers and activators of transcription, and nuclear factor-κB pathways was corroborated by nuclear expression of phosphorylated AKT, signal transducers and activators of transcription 3, and RelA in NKTCL, and several deregulated genes in these pathways mapped to regions of recurrent copy number aberrations (AKT3 [1q44], IL6R [1q21.3], CCL2 [17q12], TNFRSF21 [6p12.3]). Several features of NKTCL uncovered by this analysis suggest perturbation of angiogenic pathways. Integrative analysis also evidenced deregulation of the tumor suppressor HACE1 in the frequently deleted 6q21 region. This study highlights emerging oncogenic pathways in NKTCL and identifies novel diagnostic and therapeutic targets.
AbstractList Biopsies and cell lines of natural killer/T-cell lymphoma, nasal type (NKTCL) were subject to combined gene expression profiling and array-based comparative genomic hybridization analyses. Compared with peripheral T-cell lymphoma, not otherwise specified, NKTCL had greater transcript levels for NK-cell and cytotoxic molecules, especially granzyme H. Compared with normal NKcells, tumors were closer to activated than resting cells and overexpressed several genes related to vascular biology, Epstein-Barr Virus-induced genes, and PDGFRA. Notably, platelet-derived growth factor receptor alpha and its phosphorylated form were confirmed at the protein level, and in vitro the MEC04 NKTCL cell line was sensitive to imatinib. Deregulation of the AKT, Janus kinase-signal transducers and activators of transcription, and nuclear factor-kappaB pathways was corroborated by nuclear expression of phosphorylated AKT, signal transducers and activators of transcription 3, and RelA in NKTCL, and several deregulated genes in these pathways mapped to regions of recurrent copy number aberrations (AKT3 [1q44], IL6R [1q21.3], CCL2 [17q12], TNFRSF21 [6p12.3]). Several features of NKTCL uncovered by this analysis suggest perturbation of angiogenic pathways. Integrative analysis also evidenced deregulation of the tumor suppressor HACE1 in the frequently deleted 6q21 region. This study highlights emerging oncogenic pathways in NKTCL and identifies novel diagnostic and therapeutic targets.Biopsies and cell lines of natural killer/T-cell lymphoma, nasal type (NKTCL) were subject to combined gene expression profiling and array-based comparative genomic hybridization analyses. Compared with peripheral T-cell lymphoma, not otherwise specified, NKTCL had greater transcript levels for NK-cell and cytotoxic molecules, especially granzyme H. Compared with normal NKcells, tumors were closer to activated than resting cells and overexpressed several genes related to vascular biology, Epstein-Barr Virus-induced genes, and PDGFRA. Notably, platelet-derived growth factor receptor alpha and its phosphorylated form were confirmed at the protein level, and in vitro the MEC04 NKTCL cell line was sensitive to imatinib. Deregulation of the AKT, Janus kinase-signal transducers and activators of transcription, and nuclear factor-kappaB pathways was corroborated by nuclear expression of phosphorylated AKT, signal transducers and activators of transcription 3, and RelA in NKTCL, and several deregulated genes in these pathways mapped to regions of recurrent copy number aberrations (AKT3 [1q44], IL6R [1q21.3], CCL2 [17q12], TNFRSF21 [6p12.3]). Several features of NKTCL uncovered by this analysis suggest perturbation of angiogenic pathways. Integrative analysis also evidenced deregulation of the tumor suppressor HACE1 in the frequently deleted 6q21 region. This study highlights emerging oncogenic pathways in NKTCL and identifies novel diagnostic and therapeutic targets.
Biopsies and cell lines of natural killer/T-cell lymphoma, nasal type (NKTCL) were subject to combined gene expression profiling and array-based comparative genomic hybridization analyses. Compared with peripheral T-cell lymphoma, not otherwise specified, NKTCL had greater transcript levels for NK-cell and cytotoxic molecules, especially granzyme H. Compared with normal NKcells, tumors were closer to activated than resting cells and overexpressed several genes related to vascular biology, Epstein-Barr Virus–induced genes, and PDGFRA . Notably, platelet-derived growth factor receptor α and its phosphorylated form were confirmed at the protein level, and in vitro the MEC04 NKTCL cell line was sensitive to imatinib. Deregulation of the AKT, Janus kinase–signal transducers and activators of transcription, and nuclear factor-κB pathways was corroborated by nuclear expression of phosphorylated AKT, signal transducers and activators of transcription 3, and RelA in NKTCL, and several deregulated genes in these pathways mapped to regions of recurrent copy number aberrations ( AKT3 [1q44], IL6R [1q21.3], CCL2 [17q12], TNFRSF21 [6p12.3]). Several features of NKTCL uncovered by this analysis suggest perturbation of angiogenic pathways. Integrative analysis also evidenced deregulation of the tumor suppressor HACE1 in the frequently deleted 6q21 region. This study highlights emerging oncogenic pathways in NKTCL and identifies novel diagnostic and therapeutic targets.
Biopsies and cell lines of natural killer/T-cell lymphoma, nasal type (NKTCL) were subject to combined gene expression profiling and array-based comparative genomic hybridization analyses. Compared with peripheral T-cell lymphoma, not otherwise specified, NKTCL had greater transcript levels for NK-cell and cytotoxic molecules, especially granzyme H. Compared with normal NKcells, tumors were closer to activated than resting cells and overexpressed several genes related to vascular biology, Epstein-Barr Virus-induced genes, and PDGFRA. Notably, platelet-derived growth factor receptor alpha and its phosphorylated form were confirmed at the protein level, and in vitro the MEC04 NKTCL cell line was sensitive to imatinib. Deregulation of the AKT, Janus kinase-signal transducers and activators of transcription, and nuclear factor-kappaB pathways was corroborated by nuclear expression of phosphorylated AKT, signal transducers and activators of transcription 3, and RelA in NKTCL, and several deregulated genes in these pathways mapped to regions of recurrent copy number aberrations (AKT3 [1q44], IL6R [1q21.3], CCL2 [17q12], TNFRSF21 [6p12.3]). Several features of NKTCL uncovered by this analysis suggest perturbation of angiogenic pathways. Integrative analysis also evidenced deregulation of the tumor suppressor HACE1 in the frequently deleted 6q21 region. This study highlights emerging oncogenic pathways in NKTCL and identifies novel diagnostic and therapeutic targets.
Biopsies and cell lines of natural killer/T-cell lymphoma, nasal type (NKTCL) were subject to combined gene expression profiling and array-based comparative genomic hybridization analyses. Compared with peripheral T-cell lymphoma, not otherwise specified, NKTCL had greater transcript levels for NK-cell and cytotoxic molecules, especially granzyme H. Compared with normal NKcells, tumors were closer to activated than resting cells and overexpressed several genes related to vascular biology, Epstein-Barr Virus–induced genes, and PDGFRA. Notably, platelet-derived growth factor receptor α and its phosphorylated form were confirmed at the protein level, and in vitro the MEC04 NKTCL cell line was sensitive to imatinib. Deregulation of the AKT, Janus kinase–signal transducers and activators of transcription, and nuclear factor-κB pathways was corroborated by nuclear expression of phosphorylated AKT, signal transducers and activators of transcription 3, and RelA in NKTCL, and several deregulated genes in these pathways mapped to regions of recurrent copy number aberrations (AKT3 [1q44], IL6R [1q21.3], CCL2 [17q12], TNFRSF21 [6p12.3]). Several features of NKTCL uncovered by this analysis suggest perturbation of angiogenic pathways. Integrative analysis also evidenced deregulation of the tumor suppressor HACE1 in the frequently deleted 6q21 region. This study highlights emerging oncogenic pathways in NKTCL and identifies novel diagnostic and therapeutic targets.
Author Marafioti, Teresa
Bosq, Jacques
Coppo, Paul
de Leval, Laurence
Delfau-Larue, Marie-Hélène
Ghazi, Bouchra
Martin-Garcia, Nadine
Schmitt, Christian
de Reyniès, Aurélien
Petit, Barbara
Emile, Jean-François
Huang, Yenlin
Gaulard, Philippe
Travert, Marion
Thomas, Emilie
Brière, Josette
Author_xml – sequence: 1
  givenname: Yenlin
  surname: Huang
  fullname: Huang, Yenlin
  organization: Inserm U955, Créteil, France
– sequence: 2
  givenname: Aurélien
  surname: de Reyniès
  fullname: de Reyniès, Aurélien
  organization: Ligue Nationale Contre le Cancer, Paris, France
– sequence: 3
  givenname: Laurence
  surname: de Leval
  fullname: de Leval, Laurence
  organization: Pathology Department, Centre Hospitalo-Universitaire (CHU) Sart Tilman, University of Liège, Liège, Belgium
– sequence: 4
  givenname: Bouchra
  surname: Ghazi
  fullname: Ghazi, Bouchra
  organization: Inserm U976, Hôpital Saint-Louis, Paris, France
– sequence: 5
  givenname: Nadine
  surname: Martin-Garcia
  fullname: Martin-Garcia, Nadine
  organization: Inserm U955, Créteil, France
– sequence: 6
  givenname: Marion
  surname: Travert
  fullname: Travert, Marion
  organization: Inserm U955, Créteil, France
– sequence: 7
  givenname: Jacques
  surname: Bosq
  fullname: Bosq, Jacques
  organization: Department of Medical Biology and Pathology, Institut Gustave Roussy, Villejuif, France
– sequence: 8
  givenname: Josette
  surname: Brière
  fullname: Brière, Josette
  organization: Inserm U728 et Service de Pathologie, Hôpital Saint-Louis, Paris, France
– sequence: 9
  givenname: Barbara
  surname: Petit
  fullname: Petit, Barbara
  organization: Département de Pathologie, CHU Dupuytren, Limoges, France
– sequence: 10
  givenname: Emilie
  surname: Thomas
  fullname: Thomas, Emilie
  organization: Ligue Nationale Contre le Cancer, Paris, France
– sequence: 11
  givenname: Paul
  surname: Coppo
  fullname: Coppo, Paul
  organization: Service d'Hématologie et de Thérapie Cellulaire, Hôpital Saint-Antoine and Université Pierre et Marie Curie, Paris, France
– sequence: 12
  givenname: Teresa
  surname: Marafioti
  fullname: Marafioti, Teresa
  organization: The Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom
– sequence: 13
  givenname: Jean-François
  surname: Emile
  fullname: Emile, Jean-François
  organization: Service de pathologie, Hôpital Ambroise Paré, AP-HP et EA4340, Université de Versailles, Saint-Quentin-en-Yvelines, France
– sequence: 14
  givenname: Marie-Hélène
  surname: Delfau-Larue
  fullname: Delfau-Larue, Marie-Hélène
  organization: Inserm U955, Créteil, France
– sequence: 15
  givenname: Christian
  surname: Schmitt
  fullname: Schmitt, Christian
  organization: Inserm U976, Hôpital Saint-Louis, Paris, France
– sequence: 16
  givenname: Philippe
  surname: Gaulard
  fullname: Gaulard, Philippe
  email: philippe.gaulard@hmn.aphp.fr
  organization: Inserm U955, Créteil, France
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22421456$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19965620$$D View this record in MEDLINE/PubMed
BookMark eNp9UstuFDEQtFAQ2QT-AKG5IC4MaT_mxQEJRRAQEVzC2fJ4enaNPPZgexP27_FklxVwyMlSd1V1d7nOyInzDgl5TuENpS276K33Q8kAuhKqkjHKmuoRWdGKtSUAgxOyAoC6FF1DT8lZjD8AqOCsekJOadfVVc1gRe6u0GGBv-aAMRrvijn40Vjj1oUZ0CUzGowFThjWS8077dfojC5mlTZ3ahcLP2NQ6Z7gslAKyvlB2eLrl4ubUqO1hd1N88ZP6nXhVMydtJvxKXk8Khvx2eE9J98_fri5_FRef7v6fPn-utSiY6nkKIa6Exp5K5p8GqfQjhqHvm0Yb8au6qhq9AjItRItbxtFW9EjDrrXFQjOz8m7ve687adczicFZeUczKTCTnpl5L8dZzZy7W8la1nNuMgCrw4Cwf_cYkxyMnE5Szn02ygbzuuGCgYZ-eLvUccZf8zOgJcHgIpa2TE7pU084hgTjIqqzri3e5wOPsaAo9QmZYv9sqGxkoJcEiDvEyCXBEio5D4BmSz-Ix_3eJh28AnzZ9waDDJqgy5bbQLqJAdvHhb4Da7UzWU
CitedBy_id crossref_primary_10_1073_pnas_1520245113
crossref_primary_10_1097_CCO_0b013e32834b18ec
crossref_primary_10_3389_fonc_2023_1240359
crossref_primary_10_1684_ejd_2018_3490
crossref_primary_10_3390_cancers15051366
crossref_primary_10_1038_s41419_023_05833_w
crossref_primary_10_1097_PAS_0b013e318275d1a2
crossref_primary_10_1007_s00761_011_2126_5
crossref_primary_10_1007_s11899_014_0216_3
crossref_primary_10_1016_j_vetimm_2017_03_006
crossref_primary_10_3960_jslrt_20059
crossref_primary_10_1186_s13059_019_1651_1
crossref_primary_10_36829_63CTS_v8i2_948
crossref_primary_10_2174_1389450120666190227184654
crossref_primary_10_3892_or_2016_5205
crossref_primary_10_1186_s13000_022_01254_z
crossref_primary_10_15252_embr_202356815
crossref_primary_10_1111_cas_15333
crossref_primary_10_1186_1746_1596_6_79
crossref_primary_10_3892_ol_2019_10139
crossref_primary_10_1016_j_leukres_2017_01_001
crossref_primary_10_3389_fonc_2019_00515
crossref_primary_10_1016_j_beha_2019_06_005
crossref_primary_10_1016_j_ajpath_2012_09_012
crossref_primary_10_1182_blood_2011_01_293050
crossref_primary_10_1007_s12263_012_0292_8
crossref_primary_10_3324_haematol_2023_282718
crossref_primary_10_1309_AJCP83AOQTMLOJTM
crossref_primary_10_1111_his_15376
crossref_primary_10_1016_j_pathol_2024_07_002
crossref_primary_10_1038_onc_2014_316
crossref_primary_10_3109_10428194_2010_512964
crossref_primary_10_1007_s12253_011_9360_4
crossref_primary_10_1016_j_anndiagpath_2020_151623
crossref_primary_10_1517_13543784_2016_1121994
crossref_primary_10_3390_cancers13061414
crossref_primary_10_1111_j_1349_7006_2012_02321_x
crossref_primary_10_1200_JOP_18_00719
crossref_primary_10_2217_epi_13_39
crossref_primary_10_3233_CBM_192437
crossref_primary_10_1016_j_beha_2012_01_004
crossref_primary_10_1515_med_2021_0409
crossref_primary_10_3390_cancers14030597
crossref_primary_10_3390_diagnostics12020409
crossref_primary_10_3390_cancers13236021
crossref_primary_10_1016_j_exphem_2012_08_005
crossref_primary_10_1182_blood_2022015646
crossref_primary_10_1007_s00277_019_03643_9
crossref_primary_10_1186_s13045_018_0678_1
crossref_primary_10_1186_s13046_015_0133_x
crossref_primary_10_1016_j_humpath_2024_105650
crossref_primary_10_1111_1346_8138_12322
crossref_primary_10_1016_j_critrevonc_2021_103237
crossref_primary_10_1177_1010428317701648
crossref_primary_10_1016_j_prp_2015_12_010
crossref_primary_10_1038_s41467_018_03987_2
crossref_primary_10_1182_blood_2011_12_396150
crossref_primary_10_1016_j_canlet_2025_217602
crossref_primary_10_1038_s41379_021_00937_0
crossref_primary_10_1007_s12105_017_0802_5
crossref_primary_10_1007_s12105_016_0698_5
crossref_primary_10_1126_scitranslmed_3008970
crossref_primary_10_3109_10428194_2012_701293
crossref_primary_10_1371_journal_ppat_1008590
crossref_primary_10_1158_2643_3230_BCD_21_0098
crossref_primary_10_1016_S1470_2045_16_30148_6
crossref_primary_10_1182_blood_2012_06_438135
crossref_primary_10_1016_j_cdtm_2017_11_003
crossref_primary_10_1080_1062936X_2013_765912
crossref_primary_10_1002_ajh_23570
crossref_primary_10_1182_blood_2010_05_231548
crossref_primary_10_1172_JCI61205
crossref_primary_10_1097_CCO_0000000000000889
crossref_primary_10_1007_s11899_018_0460_z
crossref_primary_10_1038_s41467_019_12032_9
crossref_primary_10_1097_PAS_0b013e31824433d8
crossref_primary_10_1007_s12185_023_03537_7
crossref_primary_10_1053_j_semdp_2016_11_003
crossref_primary_10_3892_ol_2019_10059
crossref_primary_10_1182_blood_2011_07_364364
crossref_primary_10_3109_10428194_2013_819577
crossref_primary_10_1002_path_2823
crossref_primary_10_5808_GI_2016_14_3_78
crossref_primary_10_1016_j_beha_2018_07_002
crossref_primary_10_1007_s11596_020_2250_9
crossref_primary_10_1038_leu_2017_40
crossref_primary_10_1038_s41375_022_01623_z
crossref_primary_10_1158_1078_0432_CCR_14_1216
crossref_primary_10_1016_j_semcancer_2013_11_004
crossref_primary_10_3389_fonc_2023_1175545
crossref_primary_10_4049_jimmunol_1001682
crossref_primary_10_1371_journal_pone_0141906
crossref_primary_10_1038_cdd_2012_144
crossref_primary_10_1038_s41388_021_01680_1
crossref_primary_10_1186_s40164_020_00188_w
crossref_primary_10_2174_1871520621666210908103306
crossref_primary_10_3390_cancers14102483
crossref_primary_10_3109_10428194_2010_543718
crossref_primary_10_3748_wjg_v26_i27_3989
crossref_primary_10_1016_j_exphem_2023_11_006
crossref_primary_10_1038_modpathol_2015_85
crossref_primary_10_1182_blood_2011_07_364224
crossref_primary_10_7889_hct_3_1
crossref_primary_10_1186_s13045_023_01483_9
crossref_primary_10_1016_j_ctrv_2020_102065
crossref_primary_10_3748_wjg_v26_i27_3985
crossref_primary_10_1053_j_semdp_2011_02_007
crossref_primary_10_1007_s11899_012_0136_z
crossref_primary_10_3892_ol_2014_2509
crossref_primary_10_18632_oncotarget_3776
crossref_primary_10_1186_s13045_022_01293_5
crossref_primary_10_1038_leu_2010_255
crossref_primary_10_1182_blood_2012_08_450494
crossref_primary_10_1038_leu_2011_81
crossref_primary_10_1182_asheducation_2011_1_336
crossref_primary_10_1097_PPO_0b013e31821828b7
crossref_primary_10_1586_ehm_11_55
crossref_primary_10_1186_s13046_017_0601_6
crossref_primary_10_1371_journal_pone_0174136
crossref_primary_10_1016_j_ijrobp_2013_12_005
crossref_primary_10_1038_ng_3358
crossref_primary_10_3322_caac_21589
crossref_primary_10_1038_leu_2016_49
crossref_primary_10_1016_j_omto_2022_04_012
crossref_primary_10_1111_bjh_15702
crossref_primary_10_1002_hon_2588
crossref_primary_10_4143_crt_2023_1042
crossref_primary_10_1073_pnas_1115128108
crossref_primary_10_1007_s11912_017_0582_9
crossref_primary_10_1126_sciadv_aav2249
crossref_primary_10_1016_j_ijrobp_2010_10_040
crossref_primary_10_1080_10428194_2019_1654096
crossref_primary_10_1016_j_beha_2013_04_006
crossref_primary_10_1016_j_canlet_2012_12_022
crossref_primary_10_1053_j_seminhematol_2013_11_003
crossref_primary_10_18632_oncotarget_25835
crossref_primary_10_2217_ijh_14_21
crossref_primary_10_1186_s13045_019_0716_7
crossref_primary_10_1182_blood_2013_11_536359
crossref_primary_10_1016_j_tips_2010_12_005
crossref_primary_10_1016_j_blre_2015_08_003
crossref_primary_10_1182_blood_2013_01_453233
crossref_primary_10_1053_j_seminhematol_2022_10_002
crossref_primary_10_3390_cancers14215458
crossref_primary_10_3390_ijms19071931
crossref_primary_10_3390_cancers13225627
crossref_primary_10_1002_hon_2362
crossref_primary_10_1182_blood_2014_07_584953
crossref_primary_10_1051_medsci_20153111017
crossref_primary_10_1186_s12885_021_08695_7
crossref_primary_10_1016_j_leukres_2011_07_027
crossref_primary_10_1097_CCO_0b013e3283556142
crossref_primary_10_1007_s00277_024_05698_9
crossref_primary_10_1155_2011_790871
crossref_primary_10_3390_life12010073
crossref_primary_10_3892_etm_2017_4850
crossref_primary_10_1007_s12185_010_0738_y
crossref_primary_10_1016_S1470_2045_16_30205_4
crossref_primary_10_3390_cancers12102900
crossref_primary_10_1007_s12185_017_2192_6
crossref_primary_10_1016_j_pathol_2019_09_011
crossref_primary_10_1002_bmm2_12128
crossref_primary_10_1097_CCO_0b013e328349aba6
crossref_primary_10_1038_s41467_024_52826_0
crossref_primary_10_3389_fonc_2020_00223
crossref_primary_10_1080_17474086_2019_1660640
crossref_primary_10_1002_advs_202303913
crossref_primary_10_1007_s11899_015_0289_7
crossref_primary_10_1080_10428194_2018_1480772
crossref_primary_10_1080_07357907_2017_1405016
crossref_primary_10_1016_j_ccell_2020_02_005
crossref_primary_10_1097_CM9_0000000000003152
crossref_primary_10_1371_journal_pone_0091521
crossref_primary_10_1186_s13045_017_0452_9
crossref_primary_10_1111_j_1365_2141_2011_08651_x
crossref_primary_10_1016_j_mehy_2012_09_003
crossref_primary_10_1016_j_exphem_2021_12_191
crossref_primary_10_1155_2010_345053
crossref_primary_10_1186_s12943_023_01767_1
crossref_primary_10_1080_17474086_2016_1206465
crossref_primary_10_1155_2019_4860268
crossref_primary_10_3109_10428194_2013_813505
crossref_primary_10_1155_2015_435423
crossref_primary_10_3109_10428194_2011_645209
crossref_primary_10_1038_srep23695
crossref_primary_10_1002_adfm_202009946
crossref_primary_10_1182_blood_2011_04_346890
crossref_primary_10_1002_eji_201141870
crossref_primary_10_1016_j_prp_2014_02_004
crossref_primary_10_1038_leu_2014_50
crossref_primary_10_1186_s13046_017_0639_5
crossref_primary_10_1200_JCO_2011_40_7098
crossref_primary_10_1360_SSV_2024_0178
crossref_primary_10_3389_fonc_2023_1202964
crossref_primary_10_1007_s12032_014_0071_z
crossref_primary_10_3389_fonc_2019_00386
crossref_primary_10_1053_j_semdp_2021_03_004
crossref_primary_10_1111_j_1751_553X_2011_01374_x
crossref_primary_10_3390_hemato3030034
crossref_primary_10_3389_fped_2018_00405
crossref_primary_10_1038_s41598_021_89754_8
crossref_primary_10_1186_s12935_021_02296_x
crossref_primary_10_1200_JCO_2016_71_7603
crossref_primary_10_18632_oncotarget_24698
crossref_primary_10_1053_j_semdp_2019_08_001
crossref_primary_10_3892_or_2012_2055
crossref_primary_10_1016_j_humpath_2018_08_025
crossref_primary_10_1146_annurev_pathol_020117_043821
crossref_primary_10_1155_2017_3724017
crossref_primary_10_1007_s11899_010_0062_x
crossref_primary_10_1111_imr_12248
crossref_primary_10_1186_s13000_018_0765_1
crossref_primary_10_1111_j_1365_2559_2010_03704_x
crossref_primary_10_1111_his_12596
crossref_primary_10_1016_j_molimm_2010_04_020
crossref_primary_10_1186_s12885_021_09023_9
crossref_primary_10_1002_hon_2459
crossref_primary_10_3389_fonc_2023_1235711
crossref_primary_10_1186_1756_9966_33_7
crossref_primary_10_1177_1479164120942119
crossref_primary_10_1182_blood_2014_07_588970
crossref_primary_10_1016_j_humpath_2012_02_007
crossref_primary_10_1182_blood_2023021787
crossref_primary_10_1038_leu_2013_157
crossref_primary_10_1097_PAS_0000000000000365
crossref_primary_10_1007_s12185_014_1521_2
crossref_primary_10_1016_j_ajpath_2014_07_011
crossref_primary_10_1016_j_bbrc_2018_08_181
crossref_primary_10_1016_j_yexmp_2017_06_008
Cites_doi 10.1200/JCO.2008.18.5678
10.1038/sj.onc.1209301
10.1186/1471-2105-9-303
10.1177/106689690401200410
10.1038/nm1621
10.1182/blood.V95.11.3628
10.1182/blood-2006-07-025809
10.1172/JCI26833
10.1182/blood-2006-07-033142
10.1309/PNXUKA1CFJMVGCN1
10.1038/sj.bjc.6602968
10.1016/j.cancergencyto.2005.06.025
10.1002/path.2466
10.1002/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1
10.1038/nri1995
10.1182/blood.V97.3.708
10.1038/leu.2009.3
10.1186/1471-2407-7-229
10.1002/cyto.1069
10.1074/jbc.M312481200
10.1038/sj.onc.1205571
10.1101/gad.1653708
10.1002/ijc.23432
10.1016/S0002-9440(10)65454-5
10.1007/s00277-008-0539-z
10.1016/S0002-9440(10)62340-1
10.1016/S0002-9440(10)63061-1
10.1046/j.1365-2141.2003.04419.x
10.4049/jimmunol.181.2.1001
10.1038/leu.2009.91
10.1186/1471-2164-8-230
10.1002/gcc.20245
10.1182/blood-2002-09-2908
10.1158/1078-0432.CCR-07-4102
10.1016/S0002-9440(10)65667-2
10.1084/jem.20090528
10.1182/blood-2006-10-055145
10.1038/nrd2530
10.1128/JVI.76.20.10427-10436.2002
10.1200/JCO.2008.16.4558
10.1038/sj.leu.2401246
10.1182/blood-2006-10-051649
10.1182/blood-2003-01-0295
10.1182/blood.V90.10.4099
10.1038/nature07968
10.4049/jimmunol.0804272
10.1038/84867
10.1182/blood-2005-05-2056
ContentType Journal Article
Copyright 2010 American Society of Hematology
2015 INIST-CNRS
2010 by The American Society of Hematology
Copyright_xml – notice: 2010 American Society of Hematology
– notice: 2015 INIST-CNRS
– notice: 2010 by The American Society of Hematology
DBID 6I.
AAFTH
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1182/blood-2009-05-221275
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE

CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Biology
Anatomy & Physiology
EISSN 1528-0020
EndPage 1237
ExternalDocumentID PMC2826234
19965620
22421456
10_1182_blood_2009_05_221275
S0006497120492547
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.55
0R~
1CY
23N
2WC
34G
39C
4.4
53G
5GY
5RE
5VS
6I.
6J9
9M8
AAEDW
AAFTH
AAXUO
ABOCM
ABVKL
ACGFO
ADBBV
AENEX
AFFNX
AFOSN
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AQVPL
BAWUL
BTFSW
CS3
DIK
DU5
E3Z
EBS
EJD
EX3
F5P
FDB
FRP
GS5
GX1
IH2
K-O
KQ8
L7B
LSO
MJL
N4W
N9A
OK1
P2P
R.V
RHF
RHI
ROL
SJN
THE
TR2
TWZ
W2D
W8F
WH7
WOQ
WOW
X7M
YHG
YKV
ZA5
AALRI
AAYXX
ACVFH
ADCNI
ADVLN
AEUPX
AFPUW
AGCQF
AIGII
AITUG
AKBMS
AKYEP
AMRAJ
CITATION
H13
.GJ
AAQQT
AAYWO
AFETI
AI.
C1A
EFKBS
IQODW
J5H
MVM
OHT
VH1
WHG
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c492t-3e4d694ce38471523108fcedb87237f9591a7cf0e3ca48387a184beedcbc50433
ISSN 0006-4971
1528-0020
IngestDate Thu Aug 21 18:18:19 EDT 2025
Mon Jul 21 10:51:39 EDT 2025
Thu Apr 03 06:53:37 EDT 2025
Mon Jul 21 09:16:34 EDT 2025
Tue Jul 01 04:18:20 EDT 2025
Thu Apr 24 22:59:46 EDT 2025
Mon Apr 15 04:49:54 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Nose disease
Hematology
Lymphoproliferative syndrome
ENT disease
Nasal NK/T cell lymphoma
Malignant hemopathy
Non Hodgkin lymphoma
Carcinogenesis
Cancer
Gene expression profile
Language English
License This article is made available under the Elsevier license.
CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c492t-3e4d694ce38471523108fcedb87237f9591a7cf0e3ca48387a184beedcbc50433
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Y.H. and A.d.R. contributed equally to this work.
OpenAccessLink https://dx.doi.org/10.1182/blood-2009-05-221275
PMID 19965620
PQID 733671420
PQPubID 23479
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2826234
proquest_miscellaneous_733671420
pubmed_primary_19965620
pascalfrancis_primary_22421456
crossref_citationtrail_10_1182_blood_2009_05_221275
crossref_primary_10_1182_blood_2009_05_221275
elsevier_sciencedirect_doi_10_1182_blood_2009_05_221275
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-02-11
PublicationDateYYYYMMDD 2010-02-11
PublicationDate_xml – month: 02
  year: 2010
  text: 2010-02-11
  day: 11
PublicationDecade 2010
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
PublicationSeriesTitle Lymphoid Neoplasia
PublicationTitle Blood
PublicationTitleAlternate Blood
PublicationYear 2010
Publisher Elsevier Inc
Americain Society of Hematology
American Society of Hematology
Publisher_xml – name: Elsevier Inc
– name: Americain Society of Hematology
– name: American Society of Hematology
References Compagno, Lim, Grunn (bib21) 2009; 459
Coppo, Gouilleux-Gruart, Huang (bib17) 2009; 23
Taborelli, Tibiletti, Martin, Pozzi, Bertoni, Capella (bib40) 2006; 165
Jost, Ruland (bib48) 2007; 109
Lin, Chen, Chuang, Liu, Hsu (bib14) 2003; 102
Carter, Cahir-McFarland, Kieff (bib30) 2002; 76
Kim, Park, Lee (bib8) 2005; 106
Schmitz, Hansmann, Bohle (bib50) 2009; 206
Swerdlow SH, Campo E, Harris NL, et al, WHO Classification of Tumours of the Haematopoietic and Lymphoid tissues., 2008, Lyon, International Agency of Research on Cancer (IARC).
Chanudet, Ye, Ferry (bib49) 2009; 217
Kuo, Shih, Tsang (bib7) 2004; 12
Vose, Armitage, Weisenburger (bib10) 2008; 26
de Reyniès, Assie, Rickman (bib22) 2009; 27
Zhang, Ohyashiki, Takaku, Shimizu, Ohyashiki (bib15) 2006; 94
Larousserie, Bardel, Pflanz (bib24) 2005; 166
Ko, Choi, Han, Kim, Ree (bib4) 2001; 46
Yamaguchi, Kita, Miwa (bib13) 1995; 76
de Leval, Rickman, Thielen (bib18) 2007; 109
Piccaluga, Agostinelli, Califano (bib34) 2007; 117
Bossard, Belhadj, Reyes (bib9) 2007; 109
Takakuwa, Dong, Nakatsuka (bib11) 2002; 21
Teruya-Feldstein, Jaffe, Burd (bib39) 1997; 90
Dybkaer, Iqbal, Zhou (bib19) 2007; 8
Krenacs, Smyth, Bagdi (bib37) 2003; 101
Comoglio, Giordano, Trusolino (bib44) 2008; 7
Chow, Liu, Chan, Lei, Chan, Lo (bib45) 2005; 90
Rouget-Quermalet, Giustiniani, Marie-Cardine (bib31) 2006; 25
Feldman, Law, Grogg (bib6) 2008; 130
Toepoel, Joosten, Knobbe (bib29) 2008; 123
Boulland, Meignin, Leroy-Viard (bib47) 1998; 153
Yu, Kortylewski, Pardoll (bib32) 2007; 7
Tabone-Eglinger, Subra, El Sayadi (bib28) 2008; 14
Nagata, Konno, Kimura (bib16) 2001; 97
Pongers-Willemse, Verhagen, Tibbe (bib27) 1998; 12
Siu, Wong, Chan, Kwong (bib41) 1999; 155
Fellows, Gil-Parrado, Jenne, Kurschus (bib38) 2007; 110
Sakata, Someya, Omatsu (bib46) 2007; 7
Zhang, Anglesio, O'Sullivan (bib43) 2007; 13
Chen, Chang, Su, Chen (bib35) 2008; 87
Caron, Le Gallou, Lamy, Tarte, Fest (bib20) 2009; 182
Haedicke, Ho, Chott (bib2) 2000; 95
Joosten, Toepoel, Mariman, Van Zoelen (bib36) 2001; 27
Iqbal, Kucuk, Deleeuw (bib5) 2009; 23
Travert, Ame-Thomas, Pangault (bib26) 2008; 181
Sedelies, Sayers, Edwards (bib25) 2004; 279
Quintanilla-Martinez, Kremer, Keller (bib12) 2001; 159
Andrae, Gallini, Betsholtz (bib33) 2008; 22
Strimmer (bib23) 2008; 9
Sun, Su, Lin, Chen, Fang (bib42) 2003; 122
Nakashima, Tagawa, Suzuki (bib3) 2005; 44
Sedelies (2019111800233829100_B25) 2004; 279
Sun (2019111800233829100_B42) 2003; 122
Travert (2019111800233829100_B26) 2008; 181
Kuo (2019111800233829100_B7) 2004; 12
Quintanilla-Martinez (2019111800233829100_B12) 2001; 159
Dybkaer (2019111800233829100_B19) 2007; 8
Nagata (2019111800233829100_B16) 2001; 97
Chen (2019111800233829100_B35) 2008; 87
Kim (2019111800233829100_B8) 2005; 106
Joosten (2019111800233829100_B36) 2001; 27
Toepoel (2019111800233829100_B29) 2008; 123
Fellows (2019111800233829100_B38) 2007; 110
Chanudet (2019111800233829100_B49) 2009; 217
Bossard (2019111800233829100_B9) 2007; 109
Rouget-Quermalet (2019111800233829100_B31) 2006; 25
Zhang (2019111800233829100_B43) 2007; 13
Coppo (2019111800233829100_B17) 2009; 23
Compagno (2019111800233829100_B21) 2009; 459
Teruya-Feldstein (2019111800233829100_B39) 1997; 90
Sakata (2019111800233829100_B46) 2007; 7
Tabone-Eglinger (2019111800233829100_B28) 2008; 14
Haedicke (2019111800233829100_B2) 2000; 95
Zhang (2019111800233829100_B15) 2006; 94
Piccaluga (2019111800233829100_B34) 2007; 117
Nakashima (2019111800233829100_B3) 2005; 44
Comoglio (2019111800233829100_B44) 2008; 7
Schmitz (2019111800233829100_B50) 2009; 206
Iqbal (2019111800233829100_B5) 2009; 23
Pongers-Willemse (2019111800233829100_B27) 1998; 12
Andrae (2019111800233829100_B33) 2008; 22
Boulland (2019111800233829100_B47) 1998; 153
Larousserie (2019111800233829100_B24) 2005; 166
Lin (2019111800233829100_B14) 2003; 102
Swerdlow (2019111800233829100_B1) 2008
Taborelli (2019111800233829100_B40) 2006; 165
Carter (2019111800233829100_B30) 2002; 76
Vose (2019111800233829100_B10) 2008; 26
Yu (2019111800233829100_B32) 2007; 7
Takakuwa (2019111800233829100_B11) 2002; 21
Siu (2019111800233829100_B41) 1999; 155
de Reyniès (2019111800233829100_B22) 2009; 27
Yamaguchi (2019111800233829100_B13) 1995; 76
Feldman (2019111800233829100_B6) 2008; 130
Strimmer (2019111800233829100_B23) 2008; 9
Caron (2019111800233829100_B20) 2009; 182
Jost (2019111800233829100_B48) 2007; 109
Chow (2019111800233829100_B45) 2005; 90
de Leval (2019111800233829100_B18) 2007; 109
Krenacs (2019111800233829100_B37) 2003; 101
Ko (2019111800233829100_B4) 2001; 46
References_xml – volume: 153
  start-page: 1229
  year: 1998
  end-page: 1237
  ident: bib47
  article-title: Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas
  publication-title: Am J Pathol
– volume: 27
  start-page: 1108
  year: 2009
  end-page: 1115
  ident: bib22
  article-title: Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival
  publication-title: J Clin Oncol
– volume: 76
  start-page: 2351
  year: 1995
  end-page: 2356
  ident: bib13
  article-title: Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells
  publication-title: Cancer
– volume: 12
  start-page: 2006
  year: 1998
  end-page: 2014
  ident: bib27
  article-title: Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes
  publication-title: Leukemia
– volume: 97
  start-page: 708
  year: 2001
  end-page: 713
  ident: bib16
  article-title: Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus
  publication-title: Blood
– reference: Swerdlow SH, Campo E, Harris NL, et al, WHO Classification of Tumours of the Haematopoietic and Lymphoid tissues., 2008, Lyon, International Agency of Research on Cancer (IARC).
– volume: 94
  start-page: 599
  year: 2006
  end-page: 608
  ident: bib15
  article-title: Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection
  publication-title: Br J Cancer
– volume: 7
  start-page: 41
  year: 2007
  end-page: 51
  ident: bib32
  article-title: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
  publication-title: Nat Rev Immunol
– volume: 459
  start-page: 717
  year: 2009
  end-page: 721
  ident: bib21
  article-title: Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma
  publication-title: Nature
– volume: 46
  start-page: 85
  year: 2001
  end-page: 91
  ident: bib4
  article-title: Comparative genomic hybridization study of nasal-type NK/T-cell lymphoma
  publication-title: Cytometry
– volume: 9
  start-page: 303
  year: 2008
  ident: bib23
  article-title: A unified approach to false discovery rate estimation
  publication-title: BMC Bioinformatics
– volume: 101
  start-page: 3590
  year: 2003
  end-page: 3593
  ident: bib37
  article-title: The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity
  publication-title: Blood
– volume: 23
  start-page: 1667
  year: 2009
  end-page: 1678
  ident: bib17
  article-title: STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma
  publication-title: Leukemia
– volume: 7
  start-page: 504
  year: 2008
  end-page: 516
  ident: bib44
  article-title: Drug development of MET inhibitors: targeting oncogene addiction and expedience
  publication-title: Nat Rev Drug Discov
– volume: 21
  start-page: 4702
  year: 2002
  end-page: 4705
  ident: bib11
  article-title: Frequent mutations of Fas gene in nasal NK/T cell lymphoma
  publication-title: Oncogene
– volume: 102
  start-page: 2623
  year: 2003
  end-page: 2631
  ident: bib14
  article-title: CD94 transcripts imply a better prognosis in nasal-type extranodal NK/T-cell lymphoma
  publication-title: Blood
– volume: 25
  start-page: 2807
  year: 2006
  end-page: 2811
  ident: bib31
  article-title: Protocadherin 15 (PCDH15): a new secreted isoform and a potential marker for NK/T cell lymphomas
  publication-title: Oncogene
– volume: 23
  start-page: 1139
  year: 2009
  end-page: 1151
  ident: bib5
  article-title: Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies
  publication-title: Leukemia
– volume: 159
  start-page: 2095
  year: 2001
  end-page: 2105
  ident: bib12
  article-title: p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease
  publication-title: Am J Pathol
– volume: 90
  start-page: 4099
  year: 1997
  end-page: 4105
  ident: bib39
  article-title: The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease
  publication-title: Blood
– volume: 206
  start-page: 981
  year: 2009
  end-page: 989
  ident: bib50
  article-title: TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
  publication-title: J Exp Med
– volume: 22
  start-page: 1276
  year: 2008
  end-page: 1312
  ident: bib33
  article-title: Role of platelet-derived growth factors in physiology and medicine
  publication-title: Genes Dev
– volume: 12
  start-page: 375
  year: 2004
  end-page: 387
  ident: bib7
  article-title: Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities
  publication-title: Int J Surg Pathol
– volume: 7
  start-page: 229
  year: 2007
  ident: bib46
  article-title: The enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphoma
  publication-title: BMC Cancer
– volume: 44
  start-page: 247
  year: 2005
  end-page: 255
  ident: bib3
  article-title: Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK/T-cell lymphoma, nasal type
  publication-title: Genes Chromosomes Cancer
– volume: 123
  start-page: 322
  year: 2008
  end-page: 329
  ident: bib29
  article-title: Haplotype-specific expression of the human PDGFRA gene correlates with the risk of glioblastomas
  publication-title: Int J Cancer
– volume: 106
  start-page: 3785
  year: 2005
  end-page: 3790
  ident: bib8
  article-title: Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type
  publication-title: Blood
– volume: 155
  start-page: 1419
  year: 1999
  end-page: 1425
  ident: bib41
  article-title: Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia: recognition of consistent patterns of genetic alterations
  publication-title: Am J Pathol
– volume: 26
  start-page: 4124
  year: 2008
  end-page: 4130
  ident: bib10
  article-title: International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes
  publication-title: J Clin Oncol
– volume: 110
  start-page: 544
  year: 2007
  end-page: 552
  ident: bib38
  article-title: Natural killer cell-derived human granzyme H induces an alternative, caspase-independent cell-death program
  publication-title: Blood
– volume: 27
  start-page: 215
  year: 2001
  end-page: 217
  ident: bib36
  article-title: Promoter haplotype combinations of the platelet-derived growth factor alpha-receptor gene predispose to human neural tube defects
  publication-title: Nat Genet
– volume: 122
  start-page: 590
  year: 2003
  end-page: 599
  ident: bib42
  article-title: A 2.6 Mb interval on chromosome 6q25.2-q25.3 is commonly deleted in human nasal natural killer/T-cell lymphoma
  publication-title: Br J Haematol
– volume: 8
  start-page: 230
  year: 2007
  ident: bib19
  article-title: Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways
  publication-title: BMC Genomics
– volume: 95
  start-page: 3628
  year: 2000
  end-page: 3630
  ident: bib2
  article-title: Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas
  publication-title: Blood
– volume: 109
  start-page: 2183
  year: 2007
  end-page: 2189
  ident: bib9
  article-title: Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials
  publication-title: Blood
– volume: 13
  start-page: 1060
  year: 2007
  end-page: 1069
  ident: bib43
  article-title: The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers
  publication-title: Nat Med
– volume: 90
  start-page: 274
  year: 2005
  end-page: 275
  ident: bib45
  article-title: AKT plays a role in the survival of the tumor cells of extranodal NK/T-cell lymphoma, nasal type
  publication-title: Haematologica
– volume: 130
  start-page: 178
  year: 2008
  end-page: 185
  ident: bib6
  article-title: Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluorescence in situ hybridization
  publication-title: Am J Clin Pathol
– volume: 14
  start-page: 2285
  year: 2008
  end-page: 2294
  ident: bib28
  article-title: KIT mutations induce intracellular retention and activation of an immature form of the KIT protein in gastrointestinal stromal tumors
  publication-title: Clin Cancer Res
– volume: 87
  start-page: 985
  year: 2008
  end-page: 990
  ident: bib35
  article-title: The expression and prognostic significance of platelet-derived growth factor receptor alpha in mature T- and natural killer-cell lymphomas
  publication-title: Ann Hematol
– volume: 217
  start-page: 420
  year: 2009
  end-page: 430
  ident: bib49
  article-title: A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands
  publication-title: J Pathol
– volume: 279
  start-page: 26581
  year: 2004
  end-page: 26587
  ident: bib25
  article-title: Discordant regulation of granzyme H and granzyme B expression in human lymphocytes
  publication-title: J Biol Chem
– volume: 76
  start-page: 10427
  year: 2002
  end-page: 10436
  ident: bib30
  article-title: Epstein-Barr virus-induced changes in B-lymphocyte gene expression
  publication-title: J Virol
– volume: 182
  start-page: 7595
  year: 2009
  end-page: 7602
  ident: bib20
  article-title: CXCR4 expression functionally discriminates centroblasts versus centrocytes within human germinal center B cells
  publication-title: J Immunol
– volume: 109
  start-page: 2700
  year: 2007
  end-page: 2707
  ident: bib48
  article-title: Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications
  publication-title: Blood
– volume: 109
  start-page: 4952
  year: 2007
  end-page: 4963
  ident: bib18
  article-title: The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells
  publication-title: Blood
– volume: 166
  start-page: 1217
  year: 2005
  end-page: 1228
  ident: bib24
  article-title: Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells
  publication-title: Am J Pathol
– volume: 181
  start-page: 1001
  year: 2008
  end-page: 1011
  ident: bib26
  article-title: CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL
  publication-title: J Immunol
– volume: 165
  start-page: 106
  year: 2006
  end-page: 113
  ident: bib40
  article-title: Chromosome band 6q deletion pattern in malignant lymphomas
  publication-title: Cancer Genet Cytogenet
– volume: 117
  start-page: 823
  year: 2007
  end-page: 834
  ident: bib34
  article-title: Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets
  publication-title: J Clin Invest
– volume: 27
  start-page: 1108
  issue: 7
  year: 2009
  ident: 2019111800233829100_B22
  article-title: Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival.
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2008.18.5678
– volume: 25
  start-page: 2807
  issue: 19
  year: 2006
  ident: 2019111800233829100_B31
  article-title: Protocadherin 15 (PCDH15): a new secreted isoform and a potential marker for NK/T cell lymphomas.
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1209301
– volume: 9
  start-page: 303
  year: 2008
  ident: 2019111800233829100_B23
  article-title: A unified approach to false discovery rate estimation.
  publication-title: BMC Bioinformatics
  doi: 10.1186/1471-2105-9-303
– volume: 12
  start-page: 375
  issue: 4
  year: 2004
  ident: 2019111800233829100_B7
  article-title: Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities.
  publication-title: Int J Surg Pathol
  doi: 10.1177/106689690401200410
– volume: 90
  start-page: 274
  issue: 2
  year: 2005
  ident: 2019111800233829100_B45
  article-title: AKT plays a role in the survival of the tumor cells of extranodal NK/T-cell lymphoma, nasal type.
  publication-title: Haematologica
– volume: 13
  start-page: 1060
  issue: 9
  year: 2007
  ident: 2019111800233829100_B43
  article-title: The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers.
  publication-title: Nat Med
  doi: 10.1038/nm1621
– volume: 95
  start-page: 3628
  issue: 11
  year: 2000
  ident: 2019111800233829100_B2
  article-title: Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas.
  publication-title: Blood
  doi: 10.1182/blood.V95.11.3628
– volume: 109
  start-page: 2700
  issue: 7
  year: 2007
  ident: 2019111800233829100_B48
  article-title: Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications.
  publication-title: Blood
  doi: 10.1182/blood-2006-07-025809
– volume: 117
  start-page: 823
  issue: 3
  year: 2007
  ident: 2019111800233829100_B34
  article-title: Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets.
  publication-title: J Clin Invest
  doi: 10.1172/JCI26833
– volume: 109
  start-page: 2183
  issue: 5
  year: 2007
  ident: 2019111800233829100_B9
  article-title: Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
  publication-title: Blood
  doi: 10.1182/blood-2006-07-033142
– volume: 130
  start-page: 178
  issue: 2
  year: 2008
  ident: 2019111800233829100_B6
  article-title: Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluorescence in situ hybridization.
  publication-title: Am J Clin Pathol
  doi: 10.1309/PNXUKA1CFJMVGCN1
– volume: 94
  start-page: 599
  issue: 4
  year: 2006
  ident: 2019111800233829100_B15
  article-title: Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection.
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6602968
– volume: 165
  start-page: 106
  issue: 2
  year: 2006
  ident: 2019111800233829100_B40
  article-title: Chromosome band 6q deletion pattern in malignant lymphomas.
  publication-title: Cancer Genet Cytogenet
  doi: 10.1016/j.cancergencyto.2005.06.025
– volume: 217
  start-page: 420
  issue: 3
  year: 2009
  ident: 2019111800233829100_B49
  article-title: A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands.
  publication-title: J Pathol
  doi: 10.1002/path.2466
– volume: 76
  start-page: 2351
  issue: 11
  year: 1995
  ident: 2019111800233829100_B13
  article-title: Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.
  publication-title: Cancer
  doi: 10.1002/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1
– volume: 7
  start-page: 41
  issue: 1
  year: 2007
  ident: 2019111800233829100_B32
  article-title: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1995
– year: 2008
  ident: 2019111800233829100_B1
  article-title: WHO Classification of Tumours of the Haematopoietic and Lymphoid tissues.
– volume: 97
  start-page: 708
  issue: 3
  year: 2001
  ident: 2019111800233829100_B16
  article-title: Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus.
  publication-title: Blood
  doi: 10.1182/blood.V97.3.708
– volume: 23
  start-page: 1139
  issue: 6
  year: 2009
  ident: 2019111800233829100_B5
  article-title: Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies.
  publication-title: Leukemia
  doi: 10.1038/leu.2009.3
– volume: 7
  start-page: 229
  year: 2007
  ident: 2019111800233829100_B46
  article-title: The enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphoma.
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-7-229
– volume: 46
  start-page: 85
  issue: 2
  year: 2001
  ident: 2019111800233829100_B4
  article-title: Comparative genomic hybridization study of nasal-type NK/T-cell lymphoma.
  publication-title: Cytometry
  doi: 10.1002/cyto.1069
– volume: 279
  start-page: 26581
  issue: 25
  year: 2004
  ident: 2019111800233829100_B25
  article-title: Discordant regulation of granzyme H and granzyme B expression in human lymphocytes.
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M312481200
– volume: 21
  start-page: 4702
  issue: 30
  year: 2002
  ident: 2019111800233829100_B11
  article-title: Frequent mutations of Fas gene in nasal NK/T cell lymphoma.
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1205571
– volume: 22
  start-page: 1276
  issue: 10
  year: 2008
  ident: 2019111800233829100_B33
  article-title: Role of platelet-derived growth factors in physiology and medicine.
  publication-title: Genes Dev
  doi: 10.1101/gad.1653708
– volume: 123
  start-page: 322
  issue: 2
  year: 2008
  ident: 2019111800233829100_B29
  article-title: Haplotype-specific expression of the human PDGFRA gene correlates with the risk of glioblastomas.
  publication-title: Int J Cancer
  doi: 10.1002/ijc.23432
– volume: 155
  start-page: 1419
  issue: 5
  year: 1999
  ident: 2019111800233829100_B41
  article-title: Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia: recognition of consistent patterns of genetic alterations.
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)65454-5
– volume: 87
  start-page: 985
  issue: 12
  year: 2008
  ident: 2019111800233829100_B35
  article-title: The expression and prognostic significance of platelet-derived growth factor receptor alpha in mature T- and natural killer-cell lymphomas.
  publication-title: Ann Hematol
  doi: 10.1007/s00277-008-0539-z
– volume: 166
  start-page: 1217
  issue: 4
  year: 2005
  ident: 2019111800233829100_B24
  article-title: Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells.
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)62340-1
– volume: 159
  start-page: 2095
  issue: 6
  year: 2001
  ident: 2019111800233829100_B12
  article-title: p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease.
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)63061-1
– volume: 122
  start-page: 590
  issue: 4
  year: 2003
  ident: 2019111800233829100_B42
  article-title: A 2.6 Mb interval on chromosome 6q25.2-q25.3 is commonly deleted in human nasal natural killer/T-cell lymphoma.
  publication-title: Br J Haematol
  doi: 10.1046/j.1365-2141.2003.04419.x
– volume: 181
  start-page: 1001
  issue: 2
  year: 2008
  ident: 2019111800233829100_B26
  article-title: CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL.
  publication-title: J Immunol
  doi: 10.4049/jimmunol.181.2.1001
– volume: 23
  start-page: 1667
  issue: 9
  year: 2009
  ident: 2019111800233829100_B17
  article-title: STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma.
  publication-title: Leukemia
  doi: 10.1038/leu.2009.91
– volume: 8
  start-page: 230
  year: 2007
  ident: 2019111800233829100_B19
  article-title: Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways.
  publication-title: BMC Genomics
  doi: 10.1186/1471-2164-8-230
– volume: 44
  start-page: 247
  issue: 3
  year: 2005
  ident: 2019111800233829100_B3
  article-title: Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK/T-cell lymphoma, nasal type.
  publication-title: Genes Chromosomes Cancer
  doi: 10.1002/gcc.20245
– volume: 101
  start-page: 3590
  issue: 9
  year: 2003
  ident: 2019111800233829100_B37
  article-title: The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity.
  publication-title: Blood
  doi: 10.1182/blood-2002-09-2908
– volume: 14
  start-page: 2285
  issue: 8
  year: 2008
  ident: 2019111800233829100_B28
  article-title: KIT mutations induce intracellular retention and activation of an immature form of the KIT protein in gastrointestinal stromal tumors.
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-07-4102
– volume: 153
  start-page: 1229
  issue: 4
  year: 1998
  ident: 2019111800233829100_B47
  article-title: Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)65667-2
– volume: 206
  start-page: 981
  issue: 5
  year: 2009
  ident: 2019111800233829100_B50
  article-title: TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.
  publication-title: J Exp Med
  doi: 10.1084/jem.20090528
– volume: 109
  start-page: 4952
  issue: 11
  year: 2007
  ident: 2019111800233829100_B18
  article-title: The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.
  publication-title: Blood
  doi: 10.1182/blood-2006-10-055145
– volume: 7
  start-page: 504
  issue: 6
  year: 2008
  ident: 2019111800233829100_B44
  article-title: Drug development of MET inhibitors: targeting oncogene addiction and expedience.
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd2530
– volume: 76
  start-page: 10427
  issue: 20
  year: 2002
  ident: 2019111800233829100_B30
  article-title: Epstein-Barr virus-induced changes in B-lymphocyte gene expression.
  publication-title: J Virol
  doi: 10.1128/JVI.76.20.10427-10436.2002
– volume: 26
  start-page: 4124
  issue: 25
  year: 2008
  ident: 2019111800233829100_B10
  article-title: International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2008.16.4558
– volume: 12
  start-page: 2006
  issue: 12
  year: 1998
  ident: 2019111800233829100_B27
  article-title: Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes.
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2401246
– volume: 110
  start-page: 544
  issue: 2
  year: 2007
  ident: 2019111800233829100_B38
  article-title: Natural killer cell-derived human granzyme H induces an alternative, caspase-independent cell-death program.
  publication-title: Blood
  doi: 10.1182/blood-2006-10-051649
– volume: 102
  start-page: 2623
  issue: 7
  year: 2003
  ident: 2019111800233829100_B14
  article-title: CD94 transcripts imply a better prognosis in nasal-type extranodal NK/T-cell lymphoma.
  publication-title: Blood
  doi: 10.1182/blood-2003-01-0295
– volume: 90
  start-page: 4099
  issue: 10
  year: 1997
  ident: 2019111800233829100_B39
  article-title: The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease.
  publication-title: Blood
  doi: 10.1182/blood.V90.10.4099
– volume: 459
  start-page: 717
  issue: 7247
  year: 2009
  ident: 2019111800233829100_B21
  article-title: Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.
  publication-title: Nature
  doi: 10.1038/nature07968
– volume: 182
  start-page: 7595
  issue: 12
  year: 2009
  ident: 2019111800233829100_B20
  article-title: CXCR4 expression functionally discriminates centroblasts versus centrocytes within human germinal center B cells.
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0804272
– volume: 27
  start-page: 215
  issue: 2
  year: 2001
  ident: 2019111800233829100_B36
  article-title: Promoter haplotype combinations of the platelet-derived growth factor alpha-receptor gene predispose to human neural tube defects.
  publication-title: Nat Genet
  doi: 10.1038/84867
– volume: 106
  start-page: 3785
  issue: 12
  year: 2005
  ident: 2019111800233829100_B8
  article-title: Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type.
  publication-title: Blood
  doi: 10.1182/blood-2005-05-2056
SSID ssj0014325
Score 2.4669476
Snippet Biopsies and cell lines of natural killer/T-cell lymphoma, nasal type (NKTCL) were subject to combined gene expression profiling and array-based comparative...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1226
SubjectTerms Adult
Aged
Biological and medical sciences
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Blotting, Western
Cell Proliferation
Cells, Cultured
Comparative Genomic Hybridization
Epstein-Barr Virus Infections - genetics
Epstein-Barr Virus Infections - metabolism
Epstein-Barr Virus Infections - virology
Female
Gene Expression Profiling
Hematologic and hematopoietic diseases
Herpesvirus 4, Human - physiology
Humans
Immunoenzyme Techniques
Killer Cells, Natural - pathology
Killer Cells, Natural - virology
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Lymphoid Neoplasia
Lymphoma, Extranodal NK-T-Cell - genetics
Lymphoma, Extranodal NK-T-Cell - metabolism
Lymphoma, Extranodal NK-T-Cell - virology
Male
Medical sciences
Middle Aged
Nasal Mucosa - metabolism
Nasal Mucosa - pathology
Nasopharyngeal Neoplasms - genetics
Nasopharyngeal Neoplasms - metabolism
Nasopharyngeal Neoplasms - virology
Oligonucleotide Array Sequence Analysis
Oncogenes - physiology
Receptors, Platelet-Derived Growth Factor - genetics
Receptors, Platelet-Derived Growth Factor - metabolism
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger - genetics
RNA, Messenger - metabolism
Signal Transduction
Ubiquitin-Protein Ligases - genetics
Ubiquitin-Protein Ligases - metabolism
Title Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type
URI https://dx.doi.org/10.1182/blood-2009-05-221275
https://www.ncbi.nlm.nih.gov/pubmed/19965620
https://www.proquest.com/docview/733671420
https://pubmed.ncbi.nlm.nih.gov/PMC2826234
Volume 115
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdZxz5gjC3dR_ZR9DD20rl1JDuSH9uyrSxbYNBC92QcWSaGxA5NQkn_gv3Zu5Pkj2wp3fZijC3Lxvfz-U539ztC3nHNeaIUeCeh9sFBCXzQg4OBx1M_0plWXGiT5TsanJ4HXy7Ci07nZytrabUcH6jrrXUl_yNVOAZyxSrZf5BsPSkcgH2QL2xBwrD9KxkjZzRy9NtcVpNsleWmvjxPbRaQXuxjBbDtRFSoEqbKFZKpTq6S9WK_nCOnsitrATUNP64yBaGNhkgq4uGq_v50DQIvZ8bILJIFJqeD77oRDJ66jvMWH24F-geuk9TQS7E_xLrITWBe2hbIKxemBzO4Pe4rMpBXNdu6BcrPk-TaJB8clys1uUzaKxYYbGee06jaaVmkxfaZv6GGbVmnw1tbqfaZLar_U9tLZI-1Gf42yhN6zFDWt4eDzOYzgwDMuAZ7z2_-fXVGYnXqDrnLwOHAXhjD7008KuAsdIWXcNPDbbc09LN2kptsnEfzZAFfXmZbpmzzaX5PzW3ZOmdPyGPnpNAji7inpKOLLtk9KpJlOVvT99SkDZt4TJfcO672HpxUzQO75P43l7OxS64QpbRBKa1RShuU0gqltEYprVBKa5TSvKANSuloeGgxSiuMfqAGoRQR-oycf_p4dnLquXYfngoitvS4DtJBFCjN0WIK0fGQmdLpWArGRRaFUT8RKvM1RyZ-LkXSl8EYbDw1VoaH7znZKcpCvyRUSj2QKot4GIggVDqRfZGBLzyIUl-ISPQIrwQUK8eFjy1ZprHxiSWLjYSxR2sU-2FsJdwjXn3V3HLB3DJeVLKPnT1r7dQYAHzLlXsbUKlvxzCDA3yeHqEVdmKQLL7qpNDlahEjvanoB8zvkRcWSs2zOnjCc22ArB6AVPObZ4p8YijnmWTgJwWvbpzzNXnYfOpvyM7ycqXfgrm-HO-ZL-kXNgnq5w
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gene+expression+profiling+identifies+emerging+oncogenic+pathways+operating+in+extranodal+NK%2FT-cell+lymphoma%2C+nasal+type&rft.jtitle=Blood&rft.au=Huang%2C+Yenlin&rft.au=de+Reyni%C3%A8s%2C+Aur%C3%A9lien&rft.au=de+Leval%2C+Laurence&rft.au=Ghazi%2C+Bouchra&rft.date=2010-02-11&rft.eissn=1528-0020&rft.volume=115&rft.issue=6&rft.spage=1226&rft_id=info:doi/10.1182%2Fblood-2009-05-221275&rft_id=info%3Apmid%2F19965620&rft.externalDocID=19965620
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-4971&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-4971&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-4971&client=summon